Author: Lea Primožič

he European Commission’s Research and Innovation Directorate-General organised a Reality Check on implementation aspects of Horizon Europe, the EU’s research and innovation Framework Programme, as part of the Commission’s approach to better implementation and simplification.
It focused on practical experience with Horizon Europe, aiming to collect feedback on implementation from external stakeholders and identify opportunities for simplification.
Dr. Anna Sandak was among 5 panellists. She emphasized EIC portfolio approach and EIC business acceleration services, training, and coaching. However, she also pointed out current challenges the project calls are facing and suggested possible improvements.
Besides her other researchers and innovators with extensive experience across the three main pillars of Horizon Europe shared their experiences with several Horizon Europe projects.
The event brought together more than 800 participants offering a valuable platform for discussion and exchange of ideas.
Watch here the video of the event and learn more about the Horizon Europe projects.

Project REMEDY (Archibiome tattoo for resistant, responsive, and resilient cities), coordinated by Dr. Anna Sandak, InnoRenew CoE, UP IAM researcher, was featured in the newly published EU-IN Horizon Scanning Report – Engineered living materials for in situ production of therapeutics by the European Medicines Agency.

The project was presented as one of the relevant examples from the ongoing EIC Pathfinder Challenge on Engineered Living Materials (ELMs), launched by the European Innovation Council (EIC).

The REMEDY project aims to develop an archibione tattoo that uses living microbes for functional decoration, biotherapeutic effects and sustainability benefits such as carbon sequestration and bioremediation. Remedy brings life to materials.

You can read the recently published report here: Engineered living materials for in situ production of therapeutics

You can read more about the Remedy project here: https://eic-remedy.eu/?lang=en&pagename=home

The REMEDY project, funded by the European Union’s Horizon Europe programme (European Innovation Council), held its 1st progress meeting.

All project partners gathered online to discuss key project activities of each work package, discuss common challenges and plan for the project’s next tasks. Additionally, the financial aspects and reporting was presented.

The project REMEDY aims to achieve a breakthrough in fundamental research in microbiology and synthetic biology, transfer the know-how to materials science in the form of engineered living materials, and develop compatible biofabrication processes that allow personalised design in the architectural context.

For more information about REMEDY, visit the LinkedIn profile.

Dr. Wojciech Pajerski, InnoRenew CoE researcher, is attending the 50th World Chemistry Congress (50WCC), in Kuala Lumpur, Malaysia.

He is presenting the InnoRenew CoE’s sustainable research vision and bioinspired approach to materials science. Specifically, Dr. Pajerski is showcasing the institute’s efforts in developing Engineered Living Materials (ELMs) through the following projects:

• REMEDY (Archibiome Tattoo for Resistant, Responsive, and Resilient Cities) – funded by the European Innovation Council (EIC)
• ARCHI-SKIN (Bioinspired living skin for architecture) – funded by the European Research Council (ERC)
• Biolumicoat (Bioluminescent microbial coating for architectural surfaces) – MSCA Seal of Excellence project supported by ARIS

We’re showcasing cutting-edge developments in engineered living materials and bioinspired technologies, supported by leading European and Slovenian research initiatives. Join us at LIGNA 2025 (26–30 May, Hannover, Germany), where InnoRenew CoE is proud to co-exhibit with Ledinek Engineering in Hall 27, Stand C20.

Dr. Anna Sandak at INL Colloquia Series 2025

Dr. Anna Sandak, InnoRenew CoE Deputy director, was a featured speaker for the May edition of the INL Colloquia Series 2025, held in Braga, Portugal.

In her talk »Designing with life: engineering the next generation of building materials« she shared her visionary work on Engineered Living Materials (ELMs) — a new class of bio-integrated materials that bring adaptability, self-regeneration, and environmental responsiveness into the built environment.

She highlighted the groundbreaking research from two major EU-funded projects: ARCHI-SKIN, which develops living coating systems for buildings using fungal biofilms, and REMEDY, a new initiative exploring bespoke, living layers for architecture — so-called archibiome tattoos — that blend aesthetics with functionality.

The INL Colloquia Series 2025 is an inspiring monthly event that delves into cutting-edge science and engineering. It brings together high-level, visionary researchers who are pushing the boundaries of their fields. Each month explores a new theme, sparking fresh perspectives and lively discussions.

Watch the video of Dr. Anna Sandak’s presentation bellow.

Dr. Anna Sandak at the Advanced Innovative Materials for Health workshop

Dr. Anna Sandak, REMEDY project coordinator, attended the Advanced Innovative Materials for Health workshop, held in Braga, Portugal. The event brought together researchers and innovators to explore the future of healthcare technologies, emphasizing the crucial role of new innovative materials such as Engineered Living Materials (ELMs).
REMEDY project was presented as part of the EIC ELMs portfolio, highlighting its contribution to shaping the future of healthcare, which lies in smart, safe, and sustainable innovation.
The workshop was organized by the European Commission’s Technology Council for Advanced Materials and INL – International Iberian Nanotechnology Laboratory, and was a great opportunity to foster collaboration and knowledge exchange.